nodes	percent_of_prediction	percent_of_DWPC	metapath
Alprenolol—ADRB2—Signaling by GPCR—F2—malignant glioma	0.000717	0.000717	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—NOTCH1—malignant glioma	0.000713	0.000713	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—AKT2—malignant glioma	0.000706	0.000706	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—BDKRB2—malignant glioma	0.000704	0.000704	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—PIK3CG—malignant glioma	0.000701	0.000701	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—F2—malignant glioma	0.000701	0.000701	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—CD80—malignant glioma	0.000699	0.000699	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—APC—malignant glioma	0.000698	0.000698	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—PIK3CG—malignant glioma	0.000698	0.000698	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—AKT2—malignant glioma	0.000691	0.000691	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—EGF—malignant glioma	0.00069	0.00069	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—PTPN11—malignant glioma	0.000689	0.000689	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—PIK3CG—malignant glioma	0.000686	0.000686	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—PTPN11—malignant glioma	0.000685	0.000685	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—NOTCH2—malignant glioma	0.000684	0.000684	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—PIK3CD—malignant glioma	0.000679	0.000679	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—AKT2—malignant glioma	0.000676	0.000676	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—PTPN11—malignant glioma	0.000674	0.000674	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—PIK3CG—malignant glioma	0.000671	0.000671	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—KNG1—malignant glioma	0.00067	0.00067	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—NOTCH2—malignant glioma	0.000669	0.000669	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—IDH1—malignant glioma	0.000669	0.000669	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—PIK3CD—malignant glioma	0.000664	0.000664	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—PTPN11—malignant glioma	0.000659	0.000659	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—BRAF—malignant glioma	0.000656	0.000656	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—KNG1—malignant glioma	0.000655	0.000655	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—NOTCH2—malignant glioma	0.000654	0.000654	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—PIK3CD—malignant glioma	0.000649	0.000649	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—SPHK1—malignant glioma	0.000647	0.000647	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—AKT2—malignant glioma	0.000641	0.000641	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—KNG1—malignant glioma	0.00064	0.00064	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—AKT2—malignant glioma	0.000638	0.000638	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—NTRK1—malignant glioma	0.000638	0.000638	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—EGFR—malignant glioma	0.000636	0.000636	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—CYP2C18—malignant glioma	0.000634	0.000634	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—AKT2—malignant glioma	0.000627	0.000627	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—NTRK1—malignant glioma	0.000624	0.000624	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—PIK3CD—malignant glioma	0.000616	0.000616	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—AKT2—malignant glioma	0.000614	0.000614	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—PIK3CD—malignant glioma	0.000613	0.000613	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—NTRK1—malignant glioma	0.00061	0.00061	CbGpPWpGaD
Alprenolol—ADRB3—GPCR downstream signaling—PIK3CA—malignant glioma	0.000608	0.000608	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—PIK3CD—malignant glioma	0.000603	0.000603	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—KRAS—malignant glioma	0.000601	0.000601	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—MMP3—malignant glioma	0.000593	0.000593	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—PIK3CB—malignant glioma	0.000592	0.000592	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—PIK3CD—malignant glioma	0.000589	0.000589	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—CDKN2B—malignant glioma	0.000588	0.000588	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—FGF2—malignant glioma	0.000587	0.000587	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—MMP3—malignant glioma	0.00058	0.00058	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—PIK3CB—malignant glioma	0.000579	0.000579	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—CDKN2B—malignant glioma	0.000575	0.000575	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—PTK2—malignant glioma	0.000571	0.000571	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—CXCL8—malignant glioma	0.000568	0.000568	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—MMP3—malignant glioma	0.000567	0.000567	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—PIK3CB—malignant glioma	0.000566	0.000566	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—CDKN2B—malignant glioma	0.000562	0.000562	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—HES1—malignant glioma	0.000561	0.000561	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—PTK2—malignant glioma	0.000559	0.000559	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—NCOR1—malignant glioma	0.000558	0.000558	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—CXCL8—malignant glioma	0.000556	0.000556	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—PIK3CA—malignant glioma	0.000552	0.000552	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—RAF1—malignant glioma	0.00055	0.00055	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—MDM2—malignant glioma	0.00055	0.00055	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—HES1—malignant glioma	0.000549	0.000549	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—RAF1—malignant glioma	0.000548	0.000548	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—PTK2—malignant glioma	0.000546	0.000546	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—NCOR1—malignant glioma	0.000546	0.000546	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—CXCL8—malignant glioma	0.000544	0.000544	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—IL2—malignant glioma	0.000543	0.000543	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—ERBB2—malignant glioma	0.000542	0.000542	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—RAF1—malignant glioma	0.000538	0.000538	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—PIK3CB—malignant glioma	0.000537	0.000537	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—HES1—malignant glioma	0.000537	0.000537	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—PIK3CB—malignant glioma	0.000535	0.000535	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—PDGFRA—malignant glioma	0.000534	0.000534	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—NCOR1—malignant glioma	0.000533	0.000533	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—IL2—malignant glioma	0.000531	0.000531	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—RAF1—malignant glioma	0.000526	0.000526	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—PIK3CB—malignant glioma	0.000525	0.000525	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—PDGFRA—malignant glioma	0.000522	0.000522	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—IL2—malignant glioma	0.00052	0.00052	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—SPP1—malignant glioma	0.000519	0.000519	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—CXCL8—malignant glioma	0.000516	0.000516	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—PIK3CB—malignant glioma	0.000514	0.000514	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—CXCL8—malignant glioma	0.000514	0.000514	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—GSTT1—malignant glioma	0.000513	0.000513	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—PDGFRA—malignant glioma	0.000511	0.000511	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—SPP1—malignant glioma	0.000507	0.000507	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—CXCL8—malignant glioma	0.000505	0.000505	CbGpPWpGaD
Alprenolol—ADRB3—GPCR downstream signaling—AKT1—malignant glioma	0.000496	0.000496	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—SPP1—malignant glioma	0.000496	0.000496	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—CXCL8—malignant glioma	0.000494	0.000494	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—IL2—malignant glioma	0.000493	0.000493	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—CASP3—malignant glioma	0.000492	0.000492	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—TERT—malignant glioma	0.000492	0.000492	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—IL2—malignant glioma	0.000491	0.000491	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—IL2—malignant glioma	0.000483	0.000483	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—TERT—malignant glioma	0.000481	0.000481	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—PTGS1—malignant glioma	0.000481	0.000481	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—PDGFB—malignant glioma	0.00048	0.00048	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—FGFR1—malignant glioma	0.000477	0.000477	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—IL2—malignant glioma	0.000472	0.000472	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—TERT—malignant glioma	0.00047	0.00047	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—HIF1A—malignant glioma	0.00047	0.00047	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—PDGFB—malignant glioma	0.000469	0.000469	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—FGFR1—malignant glioma	0.000467	0.000467	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—MMP9—malignant glioma	0.000465	0.000465	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—PTEN—malignant glioma	0.000462	0.000462	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—HIF1A—malignant glioma	0.00046	0.00046	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—PDGFB—malignant glioma	0.000459	0.000459	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—FGFR1—malignant glioma	0.000457	0.000457	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—CAV1—malignant glioma	0.000455	0.000455	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—AKT1—malignant glioma	0.000451	0.000451	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—HIF1A—malignant glioma	0.00045	0.00045	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—KDR—malignant glioma	0.00045	0.00045	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—BCHE—malignant glioma	0.000447	0.000447	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—CAV1—malignant glioma	0.000445	0.000445	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—SLC5A5—malignant glioma	0.000441	0.000441	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—KDR—malignant glioma	0.00044	0.00044	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—CAV1—malignant glioma	0.000435	0.000435	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—FN1—malignant glioma	0.000433	0.000433	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—F2—malignant glioma	0.000433	0.000433	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—KDR—malignant glioma	0.00043	0.00043	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—BAD—malignant glioma	0.000428	0.000428	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—NOTCH1—malignant glioma	0.000423	0.000423	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—F2—malignant glioma	0.000423	0.000423	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—FN1—malignant glioma	0.000423	0.000423	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—BAD—malignant glioma	0.000418	0.000418	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—VEGFA—malignant glioma	0.000417	0.000417	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—CD80—malignant glioma	0.000415	0.000415	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—NOTCH1—malignant glioma	0.000414	0.000414	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—APC—malignant glioma	0.000414	0.000414	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—PIK3CG—malignant glioma	0.000414	0.000414	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—FN1—malignant glioma	0.000414	0.000414	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—F2—malignant glioma	0.000414	0.000414	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—STAT3—malignant glioma	0.000413	0.000413	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—EGF—malignant glioma	0.000409	0.000409	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—BAD—malignant glioma	0.000409	0.000409	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—PTPN11—malignant glioma	0.000407	0.000407	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—CD80—malignant glioma	0.000406	0.000406	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—APC—malignant glioma	0.000405	0.000405	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—PIK3CG—malignant glioma	0.000405	0.000405	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—NOTCH1—malignant glioma	0.000405	0.000405	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—EGF—malignant glioma	0.0004	0.0004	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—PTPN11—malignant glioma	0.000398	0.000398	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—CD80—malignant glioma	0.000397	0.000397	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—APC—malignant glioma	0.000396	0.000396	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—PIK3CG—malignant glioma	0.000396	0.000396	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—EGF—malignant glioma	0.000392	0.000392	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—BRAF—malignant glioma	0.000389	0.000389	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—PTPN11—malignant glioma	0.000389	0.000389	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—MYC—malignant glioma	0.000384	0.000384	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—BRAF—malignant glioma	0.000381	0.000381	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—AKT2—malignant glioma	0.000379	0.000379	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—EGFR—malignant glioma	0.000377	0.000377	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—EGFR—malignant glioma	0.000376	0.000376	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—BRAF—malignant glioma	0.000372	0.000372	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—AKT2—malignant glioma	0.000371	0.000371	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—EGFR—malignant glioma	0.000369	0.000369	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—PIK3CD—malignant glioma	0.000364	0.000364	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—AKT2—malignant glioma	0.000362	0.000362	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—EGFR—malignant glioma	0.000361	0.000361	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—PIK3CA—malignant glioma	0.000361	0.000361	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—KRAS—malignant glioma	0.000356	0.000356	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—PIK3CD—malignant glioma	0.000356	0.000356	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—GSTP1—malignant glioma	0.000356	0.000356	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—KRAS—malignant glioma	0.000355	0.000355	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—PIK3CA—malignant glioma	0.000353	0.000353	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—KRAS—malignant glioma	0.000349	0.000349	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—FGF2—malignant glioma	0.000349	0.000349	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—PIK3CD—malignant glioma	0.000348	0.000348	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—CAT—malignant glioma	0.000346	0.000346	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—PIK3CA—malignant glioma	0.000345	0.000345	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—FGF2—malignant glioma	0.000341	0.000341	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—KRAS—malignant glioma	0.000341	0.000341	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—FGF2—malignant glioma	0.000333	0.000333	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—PIK3CA—malignant glioma	0.000327	0.000327	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—NCOR1—malignant glioma	0.000327	0.000327	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—MDM2—malignant glioma	0.000326	0.000326	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—PIK3CA—malignant glioma	0.000326	0.000326	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—RAF1—malignant glioma	0.000325	0.000325	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—ERBB2—malignant glioma	0.000322	0.000322	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—PIK3CA—malignant glioma	0.00032	0.00032	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—MDM2—malignant glioma	0.000319	0.000319	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—RAF1—malignant glioma	0.000318	0.000318	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—PIK3CB—malignant glioma	0.000317	0.000317	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—TP53—malignant glioma	0.000315	0.000315	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—ERBB2—malignant glioma	0.000315	0.000315	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—PIK3CA—malignant glioma	0.000313	0.000313	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—MDM2—malignant glioma	0.000312	0.000312	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—RAF1—malignant glioma	0.000311	0.000311	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—PIK3CB—malignant glioma	0.00031	0.00031	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—ERBB2—malignant glioma	0.000308	0.000308	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—CXCL8—malignant glioma	0.000305	0.000305	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—PIK3CB—malignant glioma	0.000304	0.000304	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—CXCL8—malignant glioma	0.000298	0.000298	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—AKT1—malignant glioma	0.000295	0.000295	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—CASP3—malignant glioma	0.000292	0.000292	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—CXCL8—malignant glioma	0.000292	0.000292	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—IL2—malignant glioma	0.000291	0.000291	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—AKT1—malignant glioma	0.000288	0.000288	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—CASP3—malignant glioma	0.000286	0.000286	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—IL2—malignant glioma	0.000285	0.000285	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—AKT1—malignant glioma	0.000282	0.000282	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—CASP3—malignant glioma	0.000279	0.000279	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—IL2—malignant glioma	0.000279	0.000279	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—MMP9—malignant glioma	0.000276	0.000276	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—PTEN—malignant glioma	0.000274	0.000274	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—MMP9—malignant glioma	0.00027	0.00027	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—PTEN—malignant glioma	0.000268	0.000268	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—AKT1—malignant glioma	0.000268	0.000268	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—CAV1—malignant glioma	0.000266	0.000266	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—AKT1—malignant glioma	0.000266	0.000266	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—MMP9—malignant glioma	0.000264	0.000264	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—PTEN—malignant glioma	0.000262	0.000262	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—AKT1—malignant glioma	0.000262	0.000262	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—AKT1—malignant glioma	0.000256	0.000256	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—VEGFA—malignant glioma	0.000248	0.000248	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—STAT3—malignant glioma	0.000245	0.000245	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—PIK3CG—malignant glioma	0.000243	0.000243	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—VEGFA—malignant glioma	0.000242	0.000242	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—STAT3—malignant glioma	0.00024	0.00024	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—VEGFA—malignant glioma	0.000237	0.000237	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—STAT3—malignant glioma	0.000235	0.000235	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—PPARG—malignant glioma	0.000234	0.000234	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—MYC—malignant glioma	0.000228	0.000228	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—MYC—malignant glioma	0.000223	0.000223	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—EGFR—malignant glioma	0.000223	0.000223	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—EGFR—malignant glioma	0.000218	0.000218	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—MYC—malignant glioma	0.000218	0.000218	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—PIK3CD—malignant glioma	0.000213	0.000213	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—EGFR—malignant glioma	0.000213	0.000213	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—KRAS—malignant glioma	0.000211	0.000211	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—KRAS—malignant glioma	0.000206	0.000206	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—KRAS—malignant glioma	0.000201	0.000201	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—PIK3CA—malignant glioma	0.000193	0.000193	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—PIK3CA—malignant glioma	0.000189	0.000189	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—TP53—malignant glioma	0.000187	0.000187	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—PIK3CB—malignant glioma	0.000186	0.000186	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—PIK3CA—malignant glioma	0.000185	0.000185	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—PTGS2—malignant glioma	0.000184	0.000184	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—TP53—malignant glioma	0.000183	0.000183	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—TP53—malignant glioma	0.000179	0.000179	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—PTEN—malignant glioma	0.000161	0.000161	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—AKT1—malignant glioma	0.000158	0.000158	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—AKT1—malignant glioma	0.000155	0.000155	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—AKT1—malignant glioma	0.000151	0.000151	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—PIK3CA—malignant glioma	0.000113	0.000113	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—AKT1—malignant glioma	9.26e-05	9.26e-05	CbGpPWpGaD
